Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis
Crossref DOI link: https://doi.org/10.1038/s41401-023-01156-w
Published Online: 2023-09-11
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Bo
Yang, Li-na
Yang, Le-tian
Liang, Yan
Guo, Fan
Fu, Ping
Ma, Liang
Text and Data Mining valid from 2023-09-11
Version of Record valid from 2023-09-11
Article History
Received: 9 April 2023
Accepted: 23 August 2023
First Online: 11 September 2023
Competing interests
: The authors declare no competing interests.